PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30483812-0	2019	Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway.	Doxorubicin	39-50	ATP binding cassette subfamily B member 1	Homo sapiens	101-105	
30483812-12	2019	Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy.	Doxorubicin	70-73	ATP binding cassette subfamily B member 1	Homo sapiens	13-43	
30483812-12	2019	Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy.	Doxorubicin	70-73	ATP binding cassette subfamily B member 1	Homo sapiens	45-49	
30483812-12	2019	Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy.	Doxorubicin	70-73	ATP binding cassette subfamily B member 1	Homo sapiens	191-195